Monacolin K supplementation in patients with hypercholesterolemia: A systematic review of clinical trials

This publication has 26 references indexed in Scilit:

• Comparing the effectiveness of Chinese patent medicines containing red yeast rice on hyperlipidaemia: A network meta‐analysis of randomized controlled trials
  Endocrinology, Diabetes & Metabolism, 2021
• Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants
  Clinical Nutrition, 2020
• The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion
  Atherosclerosis Supplements, 2019
• An overview of the bioactivity of monacolin K / lovastatin
  Food and Chemical Toxicology, 2019
• Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?
  Maturitas, 2018
• Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention
  Nutrition Research, 2016
• Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – A systematic review and meta-analysis
  Atherosclerosis, 2015
• Effects of a New Combination of Nutraceuticals with Morus alba on Lipid Profile, Insulin Sensitivity and Endotelial Function in Dyslipidemic Subjects. A Cross-Over, Randomized, Double-Blind Trial
  High Blood Pressure & Cardiovascular Prevention, 2015
• The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders
  Complementary Therapies in Medicine, 2012
• Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
  Controlled Clinical Trials, 1996